Intersect ENT, Inc. XENT
$ 28.24
0.0%
Intersect ENT, Inc. Financial Ratios 2011-2024 | XENT
Annual Financial Ratios Intersect ENT, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.2 | -19.3 | -38.5 | -65.8 | -14.6 | -17.5 | -13.1 | - | - | - |
P/S |
9.1 | 7.6 | 8.1 | 11.2 | 4.7 | 7.6 | 6.2 | - | - | - |
EV/EBITDA |
-12.1 | -19.5 | -37.7 | -65.4 | -14.4 | -16.5 | -12.9 | - | - | - |
PEG |
0.16 | 0.24 | 1.08 | -1.77 | -1.15 | -0.48 | 0.35 | - | - | - |
P/B |
11.0 | 7.0 | 7.3 | 9.2 | 3.2 | 3.6 | 4.5 | - | - | - |
P/CF |
-20.1 | -26.8 | -55.3 | -104.2 | -16.7 | -21.6 | -13.1 | - | - | - |
ROE % |
-107.92 | -36.42 | -18.94 | -13.96 | -22.05 | -20.45 | -34.12 | - | - | - |
ROA % |
-31.81 | -29.07 | -16.26 | -12.07 | -19.43 | -18.41 | -29.17 | - | - | - |
ROCE % |
-36.94 | -35.20 | -20.63 | -14.93 | -22.62 | -20.48 | -32.96 | - | - | - |
DSO |
66.1 | 63.9 | 66.0 | 62.9 | 66.9 | 68.0 | 78.9 | - | - | - |
DIO |
145.2 | 285.0 | 187.0 | 199.6 | 157.6 | 117.3 | 90.9 | - | - | - |
DPO |
72.8 | 68.0 | 100.1 | 80.1 | 91.7 | 56.7 | 76.0 | - | - | - |
All numbers in USD currency